⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Cheri QuincyD.O.

Internal Medicine · Santa Rosa, CA 95403

NPI: 1790877330

Share:

39

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers95th percentile opioid prescribingElevated long-acting opioid rate

Risk indicators are statistical patterns, not allegations. Learn more

550

Total Claims

$23K

Drug Cost

32

Beneficiaries

$707

Cost/Patient

Risk Score Breakdown 39/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+10
Long-acting opioid rate+4

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+1987%

Opioid rate vs peers

46.7% vs 2.2% avg

-50%

Cost per patient vs peers

$707 vs $1,411 avg

-33%

Brand preference vs peers

7.1% vs 10.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

⚠️

Opioid prescribing rate is 1,987% above the average for Internal Medicine providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

46.7%

Opioid Rate

257

Opioid Claims

$13K

Opioid Cost

20.6%

Long-Acting Rate

This provider's opioid prescribing rate of 46.7% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

93% generic

Brand: 39 claims · $1,815

Generic: 511 claims · $21K

Patient Profile

69

Avg Age

38%

Female

1.14

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About